Search results
Sanofi's (SNY) Dupixent Gets FDA Nod for Eczema in Infants
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) and partner Regeneron's label expansion application for Dupixent to include infants...
Sanofi's (SNY) Dupixent Gets Europe Nod for Prurigo Nodularis
Zacks via Yahoo Finance· 1 year agoSanofi SNY and partner Regeneron REGN announced that the European Commission (EC) approved their...
Sanofi (SNY) Dupixent Esophagitis Kids Study Meets Goal
Zacks via Yahoo Finance· 2 years agoSanofi's (SNY) Dupixent shows the potential to improve signs of eosinophilic esophagitis in a phase...
When my daughter's asthma medication doubled in cost, I learned we weren't the only ones paying a...
INSIDER via Yahoo News· 10 months agoGetty Images I was shocked when my daughter's monthly asthma prescription costs doubled. I learned...
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung",...
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
Investor's Business Daily· 5 months agoRegeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...
Sanofi (SNY) Relies on Dupixent and Vaccines to Drive Growth
Zacks via Yahoo Finance· 2 years agoDupixent has become the key top-line driver for Sanofi (SNY). Sanofi possesses a leading vaccine...
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%
Zacks via Yahoo Finance· 1 year agoRegeneron's (REGN) share price rose after it reported data from a late-stage study showing that...
Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review
Zacks via Yahoo Finance· 1 year agoSanofi SNY announced that the supplemental biologics license application (sBLA) for the label...
Sanofi's Dupixent gets U.S. approval to treat eczema in young children
Reuters via Yahoo News· 2 years agoDupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...